Australia Issues GMP Clearance Warning To Foreign Drug Sponsors
This article was originally published in SRA
Executive Summary
Australian regulators have warned they will no longer give sponsors of foreign-manufactured drugs the chance to correct any omissions they might make in their applications for good manufacturing practice clearance that are based on GMP certificates issued by overseas agencies under mutual recognition agreements1.